![Anastasios Konidaris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anastasios Konidaris
Finanzdirektor/CFO bei
AMNEAL PHARMACEUTICALS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Anastasios G.
Konidaris is currently Director at Zep, Inc. since 2015, Director at Kadmon Corp.
LLC since 2017, Chief Financial Officer at Amneal Intermediate, Inc. since 2020, and Chief Financial & Accounting Officer, Executive VP at Amneal Pharmaceuticals, Inc. since 2023.
Former roles include Independent Director at Delcath Systems, Inc. from 2012 to 2014, Independent Director at Kadmon Holdings, Inc. from 2017 to 2019, Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2014 to 2017, Chief Financial Officer, Director & Executive VP at Alcresta Therapeutics, Inc. from 2016 to 2020, Group Vice President at Schering-Plough Corp.
from 2003 to 2005, Chief Financial Officer & Senior Vice President at The Dun & Bradstreet Corp.
from 2005 to 2011, CFO, Executive VP & Head-Corporate Development at Ikaria, Inc. from 2011 to 2015, and Vice President-Finance-North America at Pharmacia Corp.
from 2000 to 2003.
Education includes an MBA from Drexel University and an undergraduate degree from Gwynedd-Mercy College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 449’434 ( 0.14% ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Anastasios Konidaris
| Unternehmen | Position | Beginn |
|---|---|---|
| ZEP, INC. | Direktor/Vorstandsmitglied | 01.08.2015 |
| AMNEAL PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 07.11.2023 |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2017 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Finanzdirektor/CFO | 12.03.2020 |
Ehemalige bekannte Positionen von Anastasios Konidaris
| Unternehmen | Position | Ende |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Finanzdirektor/CFO | 01.01.2020 |
| PERNIX THERAPEUTICS HOLDINGS INC | Direktor/Vorstandsmitglied | 15.11.2017 |
| IKARIA, INC. | Finanzdirektor/CFO | 01.03.2015 |
| DELCATH SYSTEMS, INC. | Direktor/Vorstandsmitglied | 11.12.2014 |
| DUN & BRADSTREET CORP | Finanzdirektor/CFO | 01.06.2011 |
Ausbildung von Anastasios Konidaris
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
The Dun & Bradstreet Corp.
 The Dun & Bradstreet Corp. Data Processing ServicesTechnology Services Provides business data and analytics services | Technology Services |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Zep, Inc.
 Zep, Inc. Household/Personal CareConsumer Non-Durables Manufactures and distributes for maintenance, cleaning & sanitation solutions | Consumer Non-Durables |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Gwynedd-Mercy College
 Gwynedd-Mercy College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Amneal Pharmaceuticals, Inc.
 Amneal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes essential medicines | Health Technology |
Wählen Sie MarketScreener 
